Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICL Performance Products is a major division of the ICL Group, specializing in the production of phosphate-based specialty chemicals for the pharmaceutical, food, and industrial sectors. The company is a leading global supplier of high-purity pharmaceutical excipients, including calcium phosphates used as diluents and binders in solid dosage forms. Their well-known product lines, such as A-Tab, Di-Tab, and TRI-TAB, are engineered to meet stringent USP/EP standards for direct compression and wet granulation. In addition to its pharmaceutical offerings, ICL Performance Products provides essential ingredients for oral care, such as polishing agents in toothpaste. The company leverages its vertical integration into phosphate rock mining to ensure a stable and high-quality supply chain for its global customer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICL Performance Products.